Mindfulness Based Stress Reduction for Hot Flashes

October 3, 2012 updated by: James Carmody, University of Massachusetts, Worcester
Stress appears to be related to hot flash frequency and intensity, and the degree of distress that women experience from their hot flashes appears to be related to their coping resources. This trial is a pilot study to test the effect of participation in a mindfulness-based stress reduction program on hot flash frequency and intensity, as well as menopause-related quality of life.

Study Overview

Status

Completed

Conditions

Detailed Description

The majority of women experience vasomotor symptoms (VMS) such as hot flashes (HF) and night sweats as they transition through menopause, and a substantial minority experience considerable distress and diminished role functioning. Until recently most women found relief through hormone therapy (HT), but concern about the health risks associated with HT has left women with few effective and safe choices for relief from their symptoms other than their own coping strategies. A variety of results from both population and laboratory studies suggest that stress and HF are correlated and that HF are more severe in women with lower coping abilities, but evidence is far from conclusive. Consequently, investigators have called for trials to evaluate the effect of stress reduction interventions on HF. Mindfulness-Based Stress Reduction (MBSR) is a widely available manualized program shown to be an effective adjunctive intervention in reducing medical symptoms and psychological distress for a wide range of stress-related disorders. In a small preliminary study using MBSR we found reductions in HF severity scores and increases in menopause-related quality of life (QOL). This R21 proposal is for a pilot randomized trial of MBSR compared to a wait-list control group for 120 menopausal women experiencing seven or more HF/day of moderate to severe intensity. It aims to:

  1. assess feasibility of recruitment, adherence to program intervention, and compliance with assessment instruments in preparation for a larger RCT; and
  2. provide preliminary estimates of efficacy of the effects of MBSR in reducing self-reported HF frequency and intensity and improving QOL.

In addition, we will use sternal skin conductance as an established objective measure of VMS in a subgroup of 15 women in each arm to test feasibility and obtain information on how objectively measured HF are related to self-reported HF in this setting. Women will be assessed at baseline, at the end of the eight-week MBSR course, and at three months after the end of the course. A secondary aim is to explore whether treatment group differences of HF frequency and intensity and QOL are explained by changes in perceived stress, health-related locus of control and mindfulness. It is anticipated that results from this pilot study will provide data needed to plan a larger more definitive randomized trial on the effect of MBSR on HF frequency and intensity and on the ability to cope with these symptoms.

Study Type

Interventional

Enrollment (Actual)

110

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Worcester, Massachusetts, United States, 01655
        • University of Massachusetts Medical School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 69 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Average of 5+ hot flashes per day
  • No menses in prior 3 months
  • Ages between 40 and 69 years
  • English speaking
  • Access to a telephone
  • Availability for the entire study period
  • Agree to maintain usual diet
  • Agree to maintain usual exercise habits
  • Consent to the study

Exclusion Criteria:

  • Psychiatric illness
  • Illness with less than one year life expectancy
  • Alcohol use ≥ 2 drinks per day
  • Current substance abuse or addiction
  • Use of selective estrogen receptor modulator (SERM) medications within the past 3 months
  • Use of HT within the past 3 months
  • Currently pregnant or breastfeeding
  • Ongoing mindfulness meditation practice

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MBSR
MBSR is an 8-week group-based program of training in mindfulness and its application to the stresses and challenges of everyday life
Other Names:
  • MBSR

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Hot flash frequency and intensity
Time Frame: Baseline, 8 weeks, 24 weeks
Baseline, 8 weeks, 24 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Menopause-related quality of life
Time Frame: Baseline, 8 weeks, 24 weeks
Baseline, 8 weeks, 24 weeks
Hot Flash-Related Daily Interference Scale
Time Frame: Baseline, 8 weeks, 24 weeks
Baseline, 8 weeks, 24 weeks
Women's Health Initiative (WHI) Insomnia Rating Scale
Time Frame: Baseline, 8 weeks, 24 weeks
Baseline, 8 weeks, 24 weeks
5 factor of Mindfulness questionnaire
Time Frame: Baseline, 8 weeks, 24 weeks
Baseline, 8 weeks, 24 weeks
Health locus of control
Time Frame: Baseline, 8 weeks, 24 weeks
Baseline, 8 weeks, 24 weeks
Perceived stress
Time Frame: Baseline, 8 weeks, 24 weeks
Baseline, 8 weeks, 24 weeks
Dietary intake
Time Frame: Baseline, 8 weeks, 24 weeks
Baseline, 8 weeks, 24 weeks
Compliance with intervention conditions
Time Frame: Baseline, 8 weeks, 24 weeks
Baseline, 8 weeks, 24 weeks
HADS
Time Frame: Baseline, 8 weeks, 24 weeks
Baseline, 8 weeks, 24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: James Carmody, PhD, University of Massachusetts, Worcester

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2005

Primary Completion (Actual)

August 1, 2012

Study Completion (Actual)

August 1, 2012

Study Registration Dates

First Submitted

April 20, 2006

First Submitted That Met QC Criteria

April 20, 2006

First Posted (Estimate)

April 24, 2006

Study Record Updates

Last Update Posted (Estimate)

October 4, 2012

Last Update Submitted That Met QC Criteria

October 3, 2012

Last Verified

October 1, 2012

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • R21AT002910-01 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on Mindfulness-based stress reduction

3
Subscribe